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Abstract
Respiratory syncytial virus (RSV) causes significant respiratory disease in children worldwide. For the study
of severe RSV disease seen in preterm infants, a suitable animal model is lacking. The novel hypothesis of this
study was that preterm lambs are susceptible to bovine RSV (bRSV) infection, an analogous pneumovirus
with ruminant host specificity, and that there would be age-dependent differences in select RSV disease
parameters. During RSV infection, preterm lambs had elevated temperatures and respiration rates with mild
anorexia and cough compared to controls. Gross lesions included multifocal consolidation and atelectasis
with foci of hyperinflation. Microscopic lesions included multifocal alveolar septal thickening and
bronchiolitis. Immunohistochemistry localized the RSV antigen to all layers of bronchiolar epithelium from a
few basal cells to numerous sloughing epithelia. A few mononuclear cells were also immunoreactive. To assess
for age-dependent differences in RSV infection, neonatal lambs were infected similarly to the preterm lambs
or with a high-titer viral inoculum. Using morphometry at day 7 of infection, preterm lambs had significantly
more cellular immunoreactivity for RSV antigen (P <0.05) and syncytial cell formation (P <0.05) than either
group of neonatal lambs. This work suggests that perinatal RSV clearance is age-dependent, which may
explain the severity of RSV infection in preterm infants. The preterm lamb model is useful for assessing age-
dependent mechanisms of severe RSV infection.
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Abstract
Respiratory syncytial virus (RSV) causes significant respiratory disease in children worldwide. For the study of severe RSV disease seen
in preterm infants, a suitable animal model is lacking. The novel hypothesis of this study was that preterm lambs are susceptible to bovine RSV
(bRSV) infection, an analogous pneumovirus with ruminant host specificity, and that there would be age-dependent differences in select RSV
disease parameters. During RSV infection, preterm lambs had elevated temperatures and respiration rates with mild anorexia and cough
compared to controls. Gross lesions included multifocal consolidation and atelectasis with foci of hyperinflation. Microscopic lesions included
multifocal alveolar septal thickening and bronchiolitis. Immunohistochemistry localized the RSV antigen to all layers of bronchiolar
epithelium from a few basal cells to numerous sloughing epithelia. A few mononuclear cells were also immunoreactive. To assess for
age-dependent differences in RSV infection, neonatal lambs were infected similarly to the preterm lambs or with a high-titer viral inoculum.
Using morphometry at day 7 of infection, preterm lambs had significantly more cellular immunoreactivity for RSV antigen (P <0.05) and
syncytial cell formation (P <0.05) than either group of neonatal lambs. This work suggests that perinatal RSV clearance is age-dependent,
which may explain the severity of RSV infection in preterm infants. The preterm lamb model is useful for assessing age-dependent
mechanisms of severe RSV infection.
© 2004 Elsevier SAS. All rights reserved.
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1. Introduction
Respiratory syncytial virus (RSV) infection is a globally
important respiratory disease of infants and children. In the
United States alone, RSV infection is the most common
cause of respiratory disease leading to hospitalization in
children, costing an estimated $300–$400 million annually
[1,2]. RSV is the major cause of bronchiolitis in children, and
the incidence of bronchiolitis hospitalization in children un-
der 1 year of age increased 2.4-fold from 1980 to 1996 [3,4].
Infection is ubiquitous and most children have been infected
by 2 years of age [5]. Currently, there is no efficacious
treatment for severe RSV infection, and supportive treatment
during hospitalization includes bronchodilators, fluid
therapy, and oxygen management, with more severe cases
receiving corticosteroids or antiviral agents (e.g. ribavirin)
[6]. Vaccine development has been slow and cautious follow-
ing a 1960s vaccine trial in which some vaccinates developed
severe disease following natural RSV exposure [7]. Recent
developments include a humanized monoclonal antibody
(palivizumab) against the fusion (F) protein, which can pre-
vent severe manifestations of RSV disease that require hos-
pitalization, but it does not prevent infection. Because of the
high costs of individual treatment, the use of palivizumab is
often restricted to high-risk patients. Patients with increased
risk for hospitalization and mortality due to severe RSV
disease include preterm and young neonatal infants [3,7,8].
Abbreviations: bRSV, bovine respiratory syncytial virus; hRSV, human
respiratory syncytial virus; RSV, respiratory syncytial virus.
* Corresponding author. Tel.: +1-515-294-7307; fax: +1-515-294-5423.
E-mail address: dmeyerho@iastate.edu (D.K. Meyerholz).
Microbes and Infection 6 (2004) 1312–1319
www.elsevier.com/locate/micinf
1286-4579/$ - see front matter © 2004 Elsevier SAS. All rights reserved.
doi:10.1016/j.micinf.2004.08.006
Currently, there is no well-recognized model for the study
of the severe RSV disease associated with preterm and young
neonatal infants. Research of severe RSV infection in infants
is limited by technical difficulty, practical and ethical con-
cerns [9]. Study of RSV infection in animal models requires
comparable clinical disease, lesion development, immunity,
or other features that relate to the specific aims of the experi-
ment [10]. Animal models for study of human RSV (hRSV)
pathogenesis and immune response include rats [11], mice
[12], ferrets [13], guinea pigs [14], hamsters [15], lambs [16]
and nonhuman primates [17]. Infection in the chimpanzee is
viewed by some to be the most analogous to human disease;
however, animal availability is limited, few are naive and
they require specialized facilities and management, making
this model impractical [18]. Mice are often used in models
for human disease (including RSV) because of the ease of
handling and availability of strains with specific knockout
genes [12]. However, hRSV infection in rodents produces
only mild bronchitis without overt respiratory disease, mak-
ing distinctions about severe infection difficult.
Late-term fetal and preterm lambs have proven valuable as
pulmonary models for the study of surfactant expression and
regulation [19], ventilation-induced injury [20], congenital
diaphragmatic hernia [21], chorioamnionitis [22], sleep ap-
nea [16] and persistent pulmonary hypertension of the new-
born [23]. A preterm lamb model of hRSV was previously
evaluated for RSV-induced sleep apnea, and infection
yielded only mild clinical disease [16]. An analogous virus
model is bovine RSV (bRSV), a pneumovirus that is genomi-
cally, antigenically and functionally related to hRSV and is
host-adapted for ruminant infection causing significant pul-
monary lesions and clinical disease [18,24,25]. The preterm
lamb model of bRSV infection has not been assessed for use
as a model of RSV disease and lesions. Previous work in the
sheep suggested, bRSV infection may cause more severe
lesions in neonatal versus 6-month-old lambs [25,26]. Fur-
thermore, study of hRSV infection in senile cotton rats sug-
gested age-dependent mechanisms for RSV clearance [11].
Since developmental age is a determinant in severity of RSV
disease and lesions, bRSV infection in the preterm lambs
could be a novel model for studying the severity of RSV
disease in preterm infants. The hypothesis of this study was
that preterm lambs are susceptible to bRSV infection and that
bRSV activity would be age-dependent in the perinatal lamb.
2. Materials and methods
2.1. Animals
Healthy, date-mated commercial ewes were acquired from
Iowa State University’s Laboratory Animal Services. A ges-
tational age of 138 days (term, 147 days) was chosen to
provide a preterm lamb, which would not require mechanical
ventilation, a known instigator of pulmonary injury [20].
Following removal via surgical uterotomy, lambs were given
tactile stimulation with manual chest compressions (if nec-
essary) until respiration was self-regulated, then dried and
placed in a thermo-regulated pen. Within the first hour, fresh
colostrum (~200 ml) was given via a stomach tube, and
ceftiofur (2.2 mg/kg per day, intramuscular) was given to
prevent potential bacterial complications [27]. Lambs were
hand-fed commercial milk replacer four times daily and milk
consumption recorded. In addition, body temperatures and
respiration rates were recorded at the same time each day
following the morning feeding. Lambs were inoculated at
1 day of age as follows: the cervical midline was sanitized
with 70% ethanol and the trachea isolated for intratracheal
injection (20 cm3) of viral inoculum (n =6) or sterile media (n
=6).
In addition, 11 neonatal lambs (2–4 days of age) were
acquired from Iowa State University’s Laboratory Animal
Resources and inoculated with bRSV similarly to the preterm
lambs, 1 day following arrival. Five of the lambs were inocu-
lated with the same virus inoculum as preterm lambs, three
lambs received high-titered viral inoculum and the remaining
three received sterile media as a control.
2.2. Virus
bRSV strain 375 was grown in flasks containing adherent
bovine turbinate cells (5% CO2 and 37 °C). When 90% of
virus-induced cytopathic effect was visible (usually within
7 days), the flasks were frozen (–80 °C) and then thawed the
next day. All flask media were pooled, thoroughly mixed,
sterile filtered and aliquoted. The aliquots were stored at
–80 °C. One aliquot was used to determine the tissue culture
infective dose (TCID50 per ml) by standard plaque assay, and
the virus titer ranged from 103–4 TCID50 per ml. For the
second group of neonatal lambs, further passages were made
to produce a high-dose inoculum with a titer 107 TCID50 per
ml.
2.3. Tissue
On day 7 of infection, lambs (preterm and neonatal) were
euthanized with an intravenous injection of sodium pentobar-
bital. From our preliminary work with bRSV in neonatal
lambs, day 7 was chosen because this is approximately when
the most severe lesions are seen and when clearance of RSV
antigen is under way [28]. The thorax was opened and the
lungs examined for gross lesions. The lungs were then re-
moved from the thorax for subsequent tissue collection. The
lung was consistently sampled from the left and right: cra-
nial, middle and caudal lobes. Tissues were placed in 10%
buffered formalin and processed routinely for hematoxylin
and eosin staining or immunohistochemistry.
2.4. Immunohistochemistry
Sections of lung on silanated glass slides were stained
with antibody to RSV antigen using a streptavidin–biotin-
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peroxidase method developed in our laboratory. Briefly,
slides of lung tissue were heated to 58 °C for 20 min and
deparaffinized through a series of ethanol and xylene baths.
Antigen retrieval was performed by applying “Pronase E”
(0.1 g Protease XIV (Sigma, St. Louis, MO) and 0.1 g CaCl2
per 100 ml TBS pH 7.6) on heated slides for 10 min followed
by Tris (pH 7.6) (5×) and PBS (Biogenex, San Ramon, CA)
washes (2×). Normal swine serum (20% for 20 min) was
applied as a nonspecific blocker followed by primary anti-
body (mouse monoclonal anti-bRSV-4 (courtesy of Dr. Ken
Platt, Iowa State University), 1:100, with normal swine se-
rum (5%) and normal goat serum (5%)) for 72 h at 4 °C.
Slides were warmed to room temperature followed by mul-
tiple PBS washes. Endogenous peroxidases were blocked by
a 40-min application of hydrogen peroxide (3%) in PBS and
then repeated PBS washes. Secondary antibody (1:300 bioti-
nylated goat anti-mouse (Kirkegaard & Perry Laboratories,
Gaithersburg, MD) with normal swine serum (15%)) was
applied for 45 min followed by multiple PBS washings.
Next, the slides were treated with streptavidin-conjugated
horseradish peroxidase (Biogenex, 45 min), multiple PBS
washes, and the chromogen Nova Red (Vector, Burlingame,
CA, 5 min). The slides were washed in PBS, counterstained
with Harris’ hematoxylin, dehydrated through a series of
ethanol and xylene baths and were coverslipped.
2.5. Morphometry
The purpose of the morphometry was to quantify the
number of cells staining for bRSV antigen in lesions. Sec-
tions of lung from the right and left cranial lobes were used
for the study. Since bRSV lesions and immunoreactivity
were principally in and around small bronchioles, a patholo-
gist (blinded from the study) randomly selected from low-
power bronchioles within lesions. At higher magnification, a
grid [29] was centered over the bronchiole and adjacent
tissue with the total number of positive cells and morphologi-
cal cell-type was recorded (area =440 ×440 µm (105.3 µm2)).
At this same time, counts for syncytial cells and mitosis were
performed. A total of 10 bronchiolar lesions were counted
from the left and right sides and averaged.
2.6. Statistics
For clinical data, the group means on each day were
analyzed for significance using pair-wise t-tests. In the mor-
phometry experiments, the resulting data was analyzed using
the Wilcoxon–Mann–Whitney test. For all data, significance
was placed at P <0.05.
3. Results
Clinical scores for the lambs included body temperature,
respiration rate and milk consumption (Table 1). The infected
preterm lambs had slightly higher temperatures than those of
control lambs throughout the infection, with significantly
higher temperatures on days 2 and 3 of infection (P
<0.05 versus control lambs). In the infected group, tempera-
tures peaked on days 2–3 of infection (39.98 ± 0.05 and 39.95
± 0.05 °C, respectively, Table 1) with a decrease until day
5 with another slight increase starting on days 6–7 of infec-
tion. From day 3 through the course of the infection, respira-
tory rates for the infected group were slightly higher than
controls, with significant elevation on days 5 and 6 of infec-
tion (P <0.05 versus control lambs). Milk consumption was
slightly reduced in the bRSV group compared to the control
group through the course of the infection. Infected lambs had
a mild cough most noticeable upon exertion.
In regards to preterm lambs and susceptibility to bRSV, all
of the infected lambs developed lung lesions, while the con-
trol lungs were normal. Grossly, the lungs had multiple
plum-red foci (2–10 mm) of consolidation that was slightly
depressed from the adjacent pleural surface. On cut-surface,
the lesions were slightly firm with well-defined borders. The
lesions were most evident on the ventral half of the lungs
with accentuation in the cranial and hilar regions. Adjacent to
the consolidated lesions were pale-pink hyperinflated areas
of lung.
Microscopically, there were multifocal areas in which
alveolar septa were thickened by macrophages, lymphocytes,
plasma cells with small numbers of neutrophils and moderate
vascular congestion (Figs. 1–3). Intralesional bronchioles
had luminal neutrophils, sloughed epithelial cells and lesser
amounts of macrophages with eosinophilic cellular and kary-
orrhectic debris (Fig. 4). Bronchiolar epithelium was often
thickened by hyperplasia of epithelial cells, many of which
had mitotic figures. There were also multiple moderate infil-
trates of neutrophils and areas of necrosis. In addition, bron-
chioles had a small number of individual apoptotic cells
usually within cytoplasmic vacuoles of adjacent epithelia or
mononuclear cells. A small number of the epithelial cells
Table 1
Average body temperature, respiration rate and daily milk consumption by
control and RSV-infected preterm lambs
Day of
infection
Group Temperature
(°C ± S.E.M.)
Respiratory rate
(respirations per
min ± S.E.M.)
Daily milk
consumption
(ml ± S.E.M.)
Day 1 Control 39.44 ± 0.17 61 ± 6.3 –
RSV 39.69 ± 0.11 57 ± 1.3 –
Day 2 Control 39.74 ± 0.06 64 ± 3.3 563.3 ± 102.0
RSV 39.98 ± 0.05 * 60 ± 2.2 498.3 ± 47.8
Day 3 Control 39.57 ± 0.13 60 ± 3.8 607.5 ± 84.6
RSV 39.95 ± 0.05 * 65 ± 2.9 583.5 ± 78.3
Day 4 Control 39.69 ± 0.06 59 ± 1.8 815.8 ± 107.7
RSV 39.78 ± 0.07 64 ± 4.8 657.5 ± 80.5
Day 5 Control 39.59 ± 0.11 50 ± 3.0 841.7 ± 100.3
RSV 39.63 ± 0.16 68 ± 5.0 * 676.7 ± 63.3
Day 6 Control 39.7 ± 0.1 52 ± 4.0 892.5 ± 91.1
RSV 39.78 ± 0.05 64 ± 3.3 * 764.2 ± 69.7
Day 7 Control 39.69 ± 0.04 49 ± 1.8 903.3 ± 106.2
RSV 39.87 ± 0.15 55 ± 1.8 785.8 ± 103.6
* RSV group compared to control group (P <0.05).
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were multinucleated (as syncytial cells) and/or contained
small (3–5 µm) intracytoplasmic eosinophilic structures con-
sistent with viral inclusion bodies.
Immunohistochemistry was used to confirm the presence
of bRSV antigen and localize the sites of cellular replication.
Sections of control lung were consistently negative. In in-
fected lung, all levels of bronchiolar epithelium were immu-
noreactive for bRSV antigen, including a few basal cells to
several sloughing epithelial cells (Fig. 5). Within lesions, a
few mononuclear cells were immunoreactive, and most had
vacuolated to foamy cytoplasms that were morphologically
consistent with macrophages. The granular cytoplasmic
staining of immunoreactive epithelial and mononuclear cells
was characterized by small globular structures (~0.5–8 µm)
within the cytoplasm and was consistent with viral inclu-
sions. A smaller number of neutrophils contained antigen.
These were often degenerate, found only in the lumen of
connecting airways and lacked distinct globular structures
(inclusions) seen in other infected cells.
Cellular immunoreactivity, syncytial cell formation and
mitotic index was used to assess RSV activity and host repair
in the preterm versus neonatal lamb. The preterm lambs had
Fig. 1. Control lungs from lambs given sterile media lacked lesions;
bar = 500 µm.
Fig. 2. bRSV-infected lungs had multiple foci of bronchointerstitial conso-
lidation; bar = 500 µm.
Fig. 3. Within lesions, the alveolar septa were thickened by predominantly
mononuclear infiltrates; bar = 100 µm.
Fig. 4. Infected bronchiolar epithelium was thickened by hyperplasia with
multiple mitotic figures (arrows) and neutrophilic necrotic cellular debris in
the lumen. Note the syncytial cell formation (arrowhead); bar = 25 µm.
Fig. 5. Staining for bRSV antigen was primarily within bronchiolar epithe-
lium and a few mononuclear cells (arrow); bar = 25 µm.
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more cellular reactivity for bRSV antigen than did neonatal
lambs with similar inocula (P <0.05) or high-titer inocula (P
<0.05) (Fig. 6A). Two out of the five lambs in neonatal group
1 (similar virus titer) and one out of three lambs in neonatal
group 2 (high virus titer) lacked evidence of immunoreactiv-
ity, while all of the preterm infected lambs had ample bRSV
antigen. The syncytial cell formation, indicative of RSV
activity, was significantly higher in the preterm group com-
pared to either of the neonatal bRSV groups (P <0.05)
(Fig. 6B). The mitotic rate, an indicator of reparative hyper-
plasia, was similar between the different groups (Fig. 6C).
4. Discussion
The hypothesis of this study was that preterm lambs
would develop bRSV disease and that bRSV antigen distri-
bution at the time of clearance would be more widespread in
preterm versus full-term neonatal lambs. The RSV-infected
preterm lambs showed clinical evidence of infection includ-
ing elevated temperature and increased respiration rate with
mild loss of appetite (milk consumption) and cough. The
pyrexia and tachypnea are consistent with previous work in
older neonatal lambs with hRSV or bRSV infection [16,25].
Infants with severe hRSV infection typically exhibit a low-
grade to moderate fever, croup-like cough and tachypnea
with anorexia, lethargy or irritability [3]. The clinical signs in
the preterm lambs paralleled many features of severe hRSV
infection in infants but notably lacked the severe croup-like
cough. This lack of severe cough is similar to previous work
in lambs with bRSV [30], but may also be, in part, a conse-
quence of the mid-tracheal inoculation, which would have
minimized exposure of the upper tracheal and laryngeal
epithelium to bRSV for development of laryngotracheitis.
All infected lambs had gross lesions, while the controls
lacked lesions. The cranioventral to hilar distribution of the
lesions was likely a partial result of the aspiration-like allo-
cation of viral media following inoculation and is similar to
other work [28]. Gross lung lesions were composed of mul-
tifocal atelectasis and consolidation with hyperinflation. In-
fants with severe hRSV infection can have radiographic
evidence of interstitial lung patterns with foci of atelectasis,
peribronchiolar thickening and hyperinflation, which corre-
sponds to lesions in this study [31].
Histologically, a bronchointerstitial pattern was seen in
multiple foci with primarily a mononuclear (macrophages
and lymphocytes) infiltrate and congestion in alveolar septa.
Severe RSV infection in infants is associated with elevated
chemokine levels including RANTES (CC chemokine ligand
5 (CCL5)) and macrophage inflammatory protein-1a
(CCL3), which are chemotactic for monocytes and other
leukocytes [31–33]. RSV-induced chemokine expression
likely provided the means for the mononuclear leukocyte
infiltrate.
The intralesional bronchioles were characterized by epi-
thelial sloughing, necrosis, and hyperplasia with infiltrates of
Fig. 6. Morphometry of cellular staining for bRSV antigen, syncytial cell
formation and mitotic rate in bRSV-inoculated preterm (20 ml × 103–4
TCID50 per ml) and neonatal (20 ml × 103–4 TCID50 per ml or 107 TCID50
per ml) lambs. A: The cellular staining for bRSV antigen was greater in the
preterm versus either neonate group (P < 0.05).All preterm lambs had strong
staining, while the neonate group had reduced individual staining, including
two of five lambs in neonate-103–4 TCID50 per ml and one of three lambs in
neonate-107 TCID50 per ml, which were negative for staining. B: Syncytial
cell formation, indicative of bRSV activity, was greater in the preterm lambs
compared to either of the neonate groups (P < 0.05). C: The mitotic rate, a
marker for the degree of reparative hyperplasia, was similar between the
preterm and neonatal groups.
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neutrophils. Leukocyte populations of the connecting airway
in severe RSV infection are typically composed of neutro-
phils, and they participate in the viral immunopathology
[34]. Epithelial sloughing and necrosis is, in part, a direct
result of neutrophil adhesion and exocytosis [35]. RSV infec-
tion of epithelial cells and monocytes leads to a synergistic
up-regulation in expression of interleukin-8 (IL-8), a CXC
chemokine that enhances neutrophilic chemotaxis, and en-
hanced IL-8 expression is correlated with severe RSV infec-
tion [36,37]. An additional source for epithelial cellular de-
bris is apoptosis, a common mechanism for clearance of
RSV-infected epithelia [27].
Adjacent bronchiolar epithelium was hyperplastic, which
is indicative of epithelial repair [38]. The mitotic rate, an
indicator of the degree of hyperplasia, was similar between
the preterm and neonatal lambs. This present study suggests
that reduced repair capacity is not likely a factor in severe
RSV disease.
Staining for bRSV antigen was present only in infected
lambs and was localized to the bronchiolar epithelium with
some mononuclear cells. Recently, putative receptor(s) for
RSV was described to have L-selectin-like properties [39].
L-Selectin is a member of the adhesion-molecule selectin
family and is important in leukocyte tethering for endothelial
transmigration during normal trafficking or at sites of inflam-
mation [40]. One of the proposed RSV receptors was further
characterized as annexin II [39]. Annexin II belongs to the
annexin family of calcium- and phospholipid-binding pro-
teins. In the lung, annexin II is selectively expressed in basal
cells, but not columnar cells of the respiratory epithelium
[41]. Infection of basal cells would be advantageous for RSV
biologically in allowing adequate time during normal cell
turnover for viral replication. While a few basal cells con-
tained antigen, most staining was in the sloughing epithelial
cells, which may correspond to the chronological turnover of
previously infected basal cells at inoculation.
The immunoreactivity in mononuclear cells and neutro-
phils could be due to direct virus infection or phagocytosis of
infected cellular debris. Direct infection is possible via puta-
tive receptors such as L-selectin-like moieties found on most
leukocytes or annexin II, which has been localized to mono-
cytes [40,42]. Ultrastructurally, macrophages of calves in-
fected with bRSV show viral inclusions in the cytoplasm
consistent with infection [43]. Most of the mononuclear cell
staining in this current study was morphologically consistent
with macrophages, and given the intracytoplasmic viral in-
clusions, direct RSV infection of macrophages was most
likely. Other mononuclear cells such as dendritic cells and
lymphocytes cannot be excluded, as in vitro studies have
shown capacity for RSV uptake [44,45]. As for neutrophil
antigen accumulation, phagocytosis of sloughed infected cel-
lular debris in airways probably allowed for much of the
neutrophil staining, since there was a lack of distinct cyto-
plasmic inclusions, and the quick demise of the degenerate
neutrophil following exocytosis into the airway lumen would
prevent opportunity for adequate viral replication.
Preterm lambs had significantly more immunoreactive
cells and syncytial cell formation than did neonatal lambs
with similar (103–4 TCID50 per ml) or even higher (107
TCID50 per ml) virus inoculum. The timing of RSV clear-
ance, as assessed by virus isolation, closely parallels staining
for bRSV antigen by immunohistochemistry [28]. Syncytial
cell formation is, in part, a by-product of the RSV fusion (F)
protein and an indicator of RSV activity [46]. The increased
bRSV immunoreactivity and syncytial cell formation in the
preterm lambs are indicative of a reduced capacity to clear
the virus compared to the neonatal lambs. Similar age-
dependent differences in viral clearance were seen while
studying severe hRSV disease, as senile versus young adult
cotton rats were less efficient at viral clearance [11]. Reduced
RSV clearance in the preterm infant would prolong and
perhaps exacerbate inflammation, leading to severe clinical
disease.
Viral clearance in bRSV-infected calves is primarily me-
diated through apoptosis of infected cells with phagocytic
removal of the apoptotic bodies by adjacent epithelial cells or
monocytic cells [27]. In cultured respiratory epithelia, RSV
infection directly results in expression of many pro- and
anti-apoptotic factors. The intracellular balance of these fac-
tors may be pushed towards apoptosis through external
mononuclear-induced cytotoxicity by binding of tumor ne-
crosis factor-related apoptosis-inducing ligand (TRAIL) to
death receptor-4/5 (DR4/5) [47]. TRAIL is quickly ex-
pressed on monocytes following interferon-a or -c activation
(common with RSV infection), and subsequent binding of
DR4/5-expressing cells causes induction of apoptosis [48].
Interestingly, lamb monocytes infected with bRSV have de-
creased phagocytosis and antigen-presentation ability [49].
In addition, preterm lamb monocytes have delayed hydrogen
peroxide production and reduced phagocytosis of apoptotic
cells compared to monocytes from neonatal lambs [50].
Decreased monocytic function in the RSV-infected preterm
infant may contribute to lack of RSV clearance and thus
allow for severe RSV disease.
In this study, we highlight the novel use of bRSV infection
in the preterm lamb, which exhibits clinical signs and com-
parable lesions to severe hRSV disease in the preterm infant.
Furthermore, preterm lambs have reduced capacity for RSV
antigen clearance compared to neonatal lambs. The preterm
lamb model is useful to study age-dependent differences seen
in severe RSV infection of preterm infants.
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